CURRENT TRENDS IN VACCINES AND VACCINOLOGY (ISSN:2631-8970)

Biography:

Dr. Hossein Hosseinkhani holds a Ph.D. in Polymer Chemistry from Kyoto University, an M.Sc. in Chemical Engineering from Tarbiat Modares University, and a B.Sc. in Chemical Engineering from Amirkabir University of Technology. He currently serves as the Founder & CEO of Matrix, Inc. Additionally, he has held various academic and industry positions, including Associate Professor at National Taiwan Univ. of Sci. and Tech., Lecturer at International Graduate Program at Academia Sinica, and Director of R&D at Centro Chino Co. and Asia Pacific Stem Cells Science, Ltd. Dr. Hosseinkhani has extensive expertise in Biomedical Engineering, Biosensors, Drug Delivery Systems, Nanotechnology, and Tissue Engineering. He has published 100 articles in peer-reviewed journals, with an H-index of 47 (Google Scholar), in addition to writing five books, nine book chapters, and one patent. Furthermore, he has presented at 258 international conferences, seminars/lectures, and served as a Special Issue Editor for several scientific journals. He also serves on the editorial board for 25 scientific journals, including Progress in Biomaterials, Drug Delivery Letters, and Nanomedicine and Nanoscience Research.

Research Interests:

Dr. Hossein Hosseinkhani is a highly skilled research expert with broad expertise in biomedical engineering, biosensors, drug delivery systems, nanotechnology, and tissue engineering. His innovative work in these fields includes developing biosensors, drug delivery systems, and nanomaterials for biomedical applications, as well as tissue regeneration strategies for bone and cartilage. His research has the potential to greatly impact human health and well-being.